William Mariner Greenman - 26 May 2023 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 May 2023
Net transactions value
-$26,912
Form type
4
Filing time
31 May 2023, 19:26:18 UTC
Previous filing
14 Mar 2023
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Options Exercise +3,300 +15% 24,798 26 May 2023 Direct F1
transaction KDNY Common Stock Sale $26,912 -1,155 -4.7% $23.30 23,643 30 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Restricted Stock Units Options Exercise $0 -3,300 -100% $0.000000* 0 26 May 2023 Common Stock 3,300 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-l trading plan previously adopted by the Reporting Person and represent shares by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.
F3 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4 100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date.